RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,058,445 | -59.2% | 958,198 | -39.1% | 0.00% | -60.0% |
| Q2 2023 | $19,771,412 | +631776.4% | 1,574,157 | +728.5% | 0.01% | +400.0% |
| Q1 2023 | $3,129 | -66.7% | 190,000 | -69.8% | 0.00% | -60.0% |
| Q4 2022 | $9,403 | -99.0% | 629,336 | +1464.2% | 0.01% | +400.0% |
| Q3 2022 | $900,000 | -71.0% | 40,234 | -78.3% | 0.00% | -50.0% |
| Q2 2022 | $3,108,000 | +654.4% | 185,557 | +1248.5% | 0.00% | – |
| Q1 2022 | $412,000 | -36.2% | 13,760 | -34.6% | 0.00% | – |
| Q4 2021 | $646,000 | -26.2% | 21,033 | -24.2% | 0.00% | – |
| Q3 2021 | $875,000 | +10.2% | 27,758 | +20.9% | 0.00% | -100.0% |
| Q1 2021 | $794,000 | -72.6% | 22,958 | -67.1% | 0.00% | -50.0% |
| Q4 2020 | $2,897,000 | – | 69,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |